Dr Edward Giles Dudley-robey, MD, NMD, CTTP | |
5514 Milagro Dr, Bakersfield, CA 93307-6893 | |
(818) 943-3713 | |
Not Available |
Full Name | Dr Edward Giles Dudley-robey |
---|---|
Gender | Male |
Speciality | Health Educator |
Location | 5514 Milagro Dr, Bakersfield, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1144515404 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Dr Edward Giles Dudley-robey, MD, NMD, CTTP 5514 Milagro Dr, Bakersfield, CA 93307-6893 Ph: (818) 943-3713 | Dr Edward Giles Dudley-robey, MD, NMD, CTTP 5514 Milagro Dr, Bakersfield, CA 93307-6893 Ph: (818) 943-3713 |
News Archive
Republican proposals to replace Medicare insurance benefits with vouchers that seniors could use to buy insurance would drive up healthcare costs for the nation's elderly, said a newly released report from the Center for American Progress Action Fund, an advocacy arm for the liberal think tank the Center for American Progress. The vouchers would not grow as quickly as healthcare costs and seniors would be required to pay the difference for plans that exceed the vouchers, the authors said.
At a U.N. Population Fund (UNFPA) meeting in Addis Ababa, Ethiopia, "[h]ealth ministers from around the world have agreed that swift action must be taken to reduce the number of women dying during pregnancy and childbirth," the BBC reports. While there appeared to be some agreement "that family planning was the most cost-effective way of [tackling] the problem ... no unanimous declaration was adopted at the Addis Ababa talks," according to the news service (10/26).
New research shows one in four chronically ill Australians is skipping healthcare because of high costs.
Iroko Pharmaceuticals, LLC today announced Phase 3 study results that showed patients treated with the company's novel, submicron particle, lower-dose diclofenac (18mg and 35mg), a non-steroidal anti-inflammatory drug (NSAID), experienced significant pain relief post surgery compared with placebo>0.01 and P<0.001 respectively).
› Verified 2 days ago